165 related articles for article (PubMed ID: 32122585)
1. Comparing PFGE, MLST, and WGS in monitoring the spread of macrolide and rifampin resistant Rhodococcus equi in horse production.
Álvarez-Narváez S; Logue CM; Barbieri NL; Berghaus LJ; Giguère S
Vet Microbiol; 2020 Mar; 242():108571. PubMed ID: 32122585
[TBL] [Abstract][Full Text] [Related]
2. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.
Giguère S; Lee E; Williams E; Cohen ND; Chaffin MK; Halbert N; Martens RJ; Franklin RP; Clark CC; Slovis NM
J Am Vet Med Assoc; 2010 Jul; 237(1):74-81. PubMed ID: 20590498
[TBL] [Abstract][Full Text] [Related]
3. Effect of Macrolide and Rifampin Resistance on the Fitness of Rhodococcus equi.
Willingham-Lane JM; Berghaus LJ; Berghaus RD; Hart KA; Giguère S
Appl Environ Microbiol; 2019 Apr; 85(7):. PubMed ID: 30683740
[No Abstract] [Full Text] [Related]
4. Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi.
Anastasi E; Giguère S; Berghaus LJ; Hondalus MK; Willingham-Lane JM; MacArthur I; Cohen ND; Roberts MC; Vazquez-Boland JA
J Antimicrob Chemother; 2015 Dec; 70(12):3184-90. PubMed ID: 26377866
[TBL] [Abstract][Full Text] [Related]
5. Macrolide- and rifampin-resistant Rhodococcus equi on a horse breeding farm, Kentucky, USA.
Burton AJ; Giguère S; Sturgill TL; Berghaus LJ; Slovis NM; Whitman JL; Levering C; Kuskie KR; Cohen ND
Emerg Infect Dis; 2013 Feb; 19(2):282-5. PubMed ID: 23347878
[TBL] [Abstract][Full Text] [Related]
6. Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
Huber L; Giguère S; Slovis NM; Carter CN; Barr BS; Cohen ND; Elam J; Erol E; Locke SJ; Phillips ED; Smith JL
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373803
[TBL] [Abstract][Full Text] [Related]
7. Identification of macrolide- and rifampicin-resistant Rhodococcus equi in environmental samples from equine breeding farms in central Kentucky during 2018.
Huber L; Giguère S; Cohen ND; Slovis NM; Berghaus L; Greiter M; Hart KA
Vet Microbiol; 2019 May; 232():74-78. PubMed ID: 31030848
[TBL] [Abstract][Full Text] [Related]
8. Effect of Macrolide and Rifampin Resistance on Fitness of
Willingham-Lane JM; Berghaus LJ; Berghaus RD; Hart KA; Giguère S
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331959
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors associated with emergence of Rhodococcus equi resistance to macrolides and rifampicin in horse-breeding farms in Kentucky, USA.
Huber L; Giguère S; Cohen ND; Slovis NM; Hanafi A; Schuckert A; Berghaus L; Greiter M; Hart KA
Vet Microbiol; 2019 Aug; 235():243-247. PubMed ID: 31383308
[TBL] [Abstract][Full Text] [Related]
10. Emergence of rifampin-resistant Rhodococcus equi in an infected foal.
Takai S; Takeda K; Nakano Y; Karasawa T; Furugoori J; Sasaki Y; Tsubaki S; Higuchi T; Anzai T; Wada R; Kamada M
J Clin Microbiol; 1997 Jul; 35(7):1904-8. PubMed ID: 9196223
[TBL] [Abstract][Full Text] [Related]
11. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
Berghaus LJ; Giguère S; Guldbech K
Vet Microbiol; 2013 Oct; 166(3-4):670-5. PubMed ID: 23915992
[TBL] [Abstract][Full Text] [Related]
12. Emergence of rifampin-resistant Rhodococcus equi with several types of mutations in the rpoB gene among AIDS patients in northern Thailand.
Asoh N; Watanabe H; Fines-Guyon M; Watanabe K; Oishi K; Kositsakulchai W; Sanchai T; Kunsuikmengrai K; Kahintapong S; Khantawa B; Tharavichitkul P; Sirisanthana T; Nagatake T
J Clin Microbiol; 2003 Jun; 41(6):2337-40. PubMed ID: 12791846
[TBL] [Abstract][Full Text] [Related]
13. Development of a multilocus sequence typing scheme for Rhodococcus equi.
Duquesne F; Houssin E; Sévin C; Duytschaever L; Tapprest J; Fretin D; Hébert L; Laugier C; Petry S
Vet Microbiol; 2017 Oct; 210():64-70. PubMed ID: 29103698
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility patterns of Rhodococcus equi from necropsied foals with rhodococcosis.
Erol E; Locke S; Saied A; Cruz Penn MJ; Smith J; Fortner J; Carter C
Vet Microbiol; 2020 Mar; 242():108568. PubMed ID: 32122582
[TBL] [Abstract][Full Text] [Related]
15. Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
Boyen F; Pasmans F; Haesebrouck F
Vet Rec; 2011 Jan; 168(4):101a. PubMed ID: 21257598
[No Abstract] [Full Text] [Related]
16. Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals.
Fines M; Pronost S; Maillard K; Taouji S; Leclercq R
J Clin Microbiol; 2001 Aug; 39(8):2784-7. PubMed ID: 11473992
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic study of results of pulsed-field gel electrophoresis of isolates of Rhodococcus equi obtained from horses and horse farms.
Cohen ND; Smith KE; Ficht TA; Takai S; Libal MC; West BR; DelRosario LS; Becu T; Leadon DP; Buckley T; Chaffin MK; Martens RJ
Am J Vet Res; 2003 Feb; 64(2):153-61. PubMed ID: 12602583
[TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi.
Coleman M; Kuskie K; Liu M; Chaffin K; Libal M; Giguère S; Bernstein L; Cohen N
Vet Microbiol; 2010 Nov; 146(1-2):175-8. PubMed ID: 20554401
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Infections Caused by Rhodococcus equi.
Giguère S
Vet Clin North Am Equine Pract; 2017 Apr; 33(1):67-85. PubMed ID: 28161038
[TBL] [Abstract][Full Text] [Related]
20. [Characterization of Rhodococcus equi isolates from horse and man].
Fuhrmann C; Lämmler C
Berl Munch Tierarztl Wochenschr; 1997 Feb; 110(2):54-9. PubMed ID: 9139629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
